Novel Approaches to Understanding, Preventing and Treating Lyme Disease and Tick-Borne Coinfections (R21)

US Dept. of Health & Human Services: National Institutes of Health (NIH)


Grant amount: Up to US $275,000

Next deadline: Jun 16, 2018

Later deadlines: Oct 16, 2018, Feb 16, 2019, Jun 16, 2019

Applicant type: Nonprofit Indigenous Group Government Entity

Funding uses: Research

Location of project: Anywhere in the world

Location of residency: Anywhere in the world

View website    Save Need help writing this grant?

Overview:

The purpose of this Funding Opportunity Announcement (FOA) is to support research that will contribute to the overall understanding of Lyme disease and co-infections transmitted by Ixodes ticks. This research opportunity encourages studies that address diverse scientific areas such as

  • pathogenesis
  • host response
  • disease transmission
  • vector biology and natural history
  • vaccines
  • diagnostics
  • therapeutics

Components of Participating Organizations: National Institute of Allergy and Infectious Diseases (NIAID) National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

You can learn more about this opportunity by visiting the funder's website.

Eligibility:

  • Eligible Organizations
    • Higher Education Institutions
    • Public/State Controlled Institutions of Higher Education
    • Private Institutions of Higher Education
    • The following types of Higher Education Institutions are always encouraged to apply for NIH support as Public or Private Institutions of Higher Education:
      • Hispanic-serving Institutions
      • Historically Black Colleges and Universities (HBCUs)
      • Tribally Controlled Colleges and Universities (TCCUs)
      • Alaska Native and Native Hawaiian Serving Institutions
      • Asian American Native American Pacific Islander Serving Institutions (AANAPISIs)
    • Nonprofits Other Than Institutions of Higher Education
      • Nonprofits with 501(c)(3) IRS Status (Other than Institutions of Higher Education
      • Nonprofits without 501(c)(3) IRS Status (Other than Institutions of Higher Education)
    • For-Profit Organizations
      • Small Businesses
      • For-Profit Organizations (Other than Small Businesses)
    • Governments
      • State Governments
      • County Governments
      • City or Township Governments
      • Special District Governments
      • Indian/Native American Tribal Governments (Federally Recognized)
      • Indian/Native American Tribal Governments (Other than Federally Recognized)
      • Eligible Agencies of the Federal Government
      • U.S. Territory or Possession
    • Other
      • Independent School Districts
      • Public Housing Authorities/Indian Housing Authorities
      • Native American Tribal Organizations (other than Federally recognized tribal governments)
      • Faith-based or Community-based Organizations
      • Regional Organizations
      • Non-domestic (non-U.S.) Entities (Foreign Institutions)
  • Foreign Institutions
    • Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply.
    • Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.
    • Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
  • Any individual(s) with the skills, knowledge, and resources necessary to carry out the proposed research as the Program Director(s)/Principal Investigator(s) (PD(s)/PI(s)) is invited to work with his/her organization to develop an application for support.
  • Applicant organizations may submit more than one application, provided that each application is scientifically distinct.

Ineligibility:

  • The NIH will not accept duplicate or highly overlapping applications under review at the same time.  This means that the NIH will not accept:
    • A new (A0) application that is submitted before issuance of the summary statement from the review of an overlapping new (A0) or resubmission (A1) application.
    • A resubmission (A1) application that is submitted before issuance of the summary statement from the review of the previous new (A0) application.
    • An application that has substantial overlap with another application pending appeal of initial peer review (see NOT-OD-11-101).